Catatonia: Another neuropsychiatric presentation of vitamin B12 deficiency?

Psychosomatics

Volumn 39, Issue 5, 1998, Pages 456-460

  Catalano, Glenn ^a   Catalano, Maria C ^b   Rosenberg, Eric I ^b   Embi, Peter J ^b   Embi, Colleen S ^b  

^a TGH University Psychiatry Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CATATONIA; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; HUMAN; INTESTINE ABSORPTION; MALE; NUTRITION; ORGANIC BRAIN SYNDROME;

EID: 0031708177     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(98)71307-6     Document Type: Letter

References (31)

1. Shakin EJ, Thompson TL: Hematologic Disorders, in Psychiatric Care of the Medical Patient, edited by Stoudemire A, Fogel BS. New York, Oxford University Press, 1993
2. 12 is associated with low serum cobalamin levels in nonvegetarians. Eur J Haematol 1991; 47:115-118
3. 12 deficiency in a patient with multiple sclerosis. Gen Hosp Psychiatry 1994; 16:224-228
4. Shorvon SD, Carney MWP, Chanarin I, et al: The neuropsychiatry of megaloblastic anaemia. BMJ 1980; 281:1036-1038
5. Jandl JH: Blood: Textbook of Hematology, 2nd Edition. Boston, MA, Little, Brown, 1996
6. 12 deficiency in psychiatric patients. J Gen Intern Med 1994; 9:522-524
7. 12 hypovitaminosis in mental diseases. Acta Medica Scandinavica 1965; 177:689-699
8. Lindenbaum J, Healton EB, Savage DG, et al: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318:1720-1728
9. 12 deficiency in multiple sclerosis inadequately documented (letter). Arch Neurol 1992; 49:680
10. Champe PC, Harvey RA (eds): Biochemistry, 2nd Edition. Philadelphia, PA, JB Lippincott, 1994, pp. 244, 326
11. Elsas LJ, Acosta PB: Nutrition support of inherited metabolic disease, in Modern Nutrition in Health and Disease, 8th Edition, edited by Shils ME, Olson JA, Shike M. Philadelphia, PA, Lea & Febiger, 1994, pp. 1147-1206
12. 12, in Present Knowledge of Nutrition, 6th Edition, edited by Brown ME. Washington DC, International Life Sciences Institute, Nutrition Foundation, 1990, pp. 170-178
13. 12 deficiency: a primarily demyelinating disease? J Neurol 1988; 235:163-164
14. 12 deficiency and psychiatry: a largely unnoticed but devastating relationship? Med Hypotheses 1991; 34:131-140
15. Addison T: On the Constitutional and Local Effects of Disease of the Supra-Renal Capsules. London, UK, Samuel Highley, 1855
16. 12 deficiency and psychiatric disorders: case report and literature review. Biol Psychiatry 1981; 16:197-205
17. 12 deficiency. J Am Geriatr Soc 1993; 41:192-193
18. Carmel R, Gott PS, Waters CH, et al: The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995; 54:245-253
19. 12 deficiency? J Am Geriatr Soc 1988; 36:1105-1112
20. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
21. Johnson J: Catatonia: the tension insanity. Br J Psychiatry 1993; 162: 733-738
22. Smith ADM: Megaloblastic madness. BMJ 1960; 2:1840-1845
23. 12: placebo or neglected therapeutic tool? Med Hypotheses 1989; 28:155-164
24. 12 deficiency. Arch Intern Med 1971; 128:596-597
25. Martin DC, Francis J, Protetch J, et al: Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992; 40:168-172
26. Greenberg DB: Cobalamin deficiency, in Textbook of Consultation-Liaison Psychiatry, edited by Rundell JR, Wise MG. Washington, DC, American Psychiatric Press, 1996, pp. 586-607
27. Jachna JS, Lane RD, Gelenberg AJ: Psychopharmacology, in Textbook of Consultation-Liaison Psychiatry, edited by Rundell JR, Wise MG. Washington, DC, American Psychiatric Press, 1996, pp. 958-1005
28. Gelenberg AJ, Mandel MR: Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977; 34:947-950
29. Stoudemire A, Luther JS: Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. Int J Psychiatry Med 1984; 14:57-63
30. Van Kammen DP, Marder SR: Dopamine-receptor antagonists, in Comprehensive Textbook of Psychiatry, VI, edited by Kaplan HI, Sadock BJ. Baltimore, MD, Williams & Wilkins, 1995, pp. 1987-2022
31. Herrmann N, Lieff SJ: Drug-induced catatonia. Can J Psychiatry 1988; 33:633-634